← Back to Patent Explorer
US4716122A Expired / Lapsed US ⏱️ 0.0 years remaining

Carrier material for use in immune determinations

Assignee: ORGANOGEN MEDIZINISCH-MOLEKULARBIOLOGISCHE FORSCHUNGSGESELLSCHAFT MBH A GERMAN CORP
•
Filing: 1985-09-26
•
Granted: 1987-12-29
•
Expires: 2005-09-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides a carrier such as polyethylene having covalently bound to it a reaction component such as an antibody, for use for immune determinations. The reaction component is covalently bound via heterobifunctional photoactivatable compounds, one group of which is found by an aryl azide group. Protein A may be bound covalently to the carrier via heterobifunctional photoactivatable compounds, and antibodies bound to the protein A.

Inventors

  • 👤 Hans Scheefers

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:16
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54353; Y; Y10; Y10S; Y10S436/00; Y10S436/828; Y10S436/905

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 45 words
A carrier having a covalently bound reaction component of an immunological reaction, for use in immune determinations comprising the reaction component covalently bound to a heterobifunctional photoactivatable compound, one group of which is formed by an aryl azide group linked to an inert polyethylene carrier.
Claim 2
Dependent Claim 45 words
A carrier having a covalently bound reaction component of an immunological reaction, for use in immune determinations comprising the reaction component covalently bound to a heterobifunctional photoactivatable compound, one group of which is formed by an aryl azide group linked to an inert polyethylene carrier.
Claim 3
Dependent Claim 44 words
The carrier according to claim 1, wherein the heterobifunctional photoactivatable compound is N-5-azidonitrobenzoyloxysuccinimide, p-azidophenacyl bromide, p-azidophenylglyoxal, 4-fluoro-3-nitrophenyl azide, methyl 4-azidobenzoimidate hydrochloride, N-succinimidyl (4-azidophenyldithio)-propionate, N-(4-azidophenylthio)-phthalimide, N-hydroxysuccinimidyl 4-azidobenzoate, N-hydroxysuccinimidyl 4-azidosalicylic acid, sulphosuccinimidyl 6-(4'-azido-2'-nitrophenylamino)-hexanoate, ethyl 4-azidophenyl-1,4-dithiobutyrimidate hydrochloride, N-succinimidyl (4-azidophenyldithio)-propionate, sulphosuccinimidyl (4-azidophenyldithio)-propionate or 4,4'-dithio-bis-phenylazide, or a combination thereof.
Claim 4
Dependent Claim 14 words
The carrier according to claim 1, wherein the heterobifunctional photoactivatable compound is N-succinimidyl 6-(4'-azido-2'-nitrophenylamino)-hexanoate.
Claim 5
Dependent Claim 15 words
The carrier according to claim 2, wherein said reaction component is a protein A-antibody complex.
Claim 6
Dependent Claim 67 words
In a process for immune determination in which one of the components participating in the immune reaction is covalently bound to a carrier material, wherein the improvement comprises binding said component via a heterobifunctional photoactivatable compound to an inert polyethylene carrier, wherein one group of said photoactivatable compound is an aryl azide group, and following the immune determination recovering the carrier material with the component bound thereon.
Claim 7
Dependent Claim 67 words
In a process for immune determination in which one of the components participating in the immune reaction is covalently bound to a carrier material, wherein the improvement comprises binding said component via a heterobifunctional photoactivatable compound to an inert polyethylene carrier, wherein one group of said photoactivatable compound is an aryl azide group, and following the immune determination recovering the carrier material with the component bound thereon.
Claim 8
Dependent Claim 12 words
Process according to claim 5, wherein the photoactivatable compound is N-succinimidyl 6-(4'-azido-2'-nitrophenylamino)-hexanoate.
Claim 9
Dependent Claim 78 words
In a process for immune determination comprising the steps of covalently binding a heterobifunctional photoactivatable compound to protein A agglutinogen from Staphylococcus aureus to form a heterobifunctional photoactivatable compound - protein A complex, covalently binding said complex to a polyethylene carrier material, binding an antibody reaction component of an immune reaction with its constant part to the protein A, carrying out the immune determination and recovering the carrier material with the complex and antibody reaction compound bound thereon.
Claim 10
Dependent Claim 78 words
In a process for immune determination comprising the steps of covalently binding a heterobifunctional photoactivatable compound to protein A agglutinogen from Staphylococcus aureus to form a heterobifunctional photoactivatable compound - protein A complex, covalently binding said complex to a polyethylene carrier material, binding an antibody reaction component of an immune reaction with its constant part to the protein A, carrying out the immune determination and recovering the carrier material with the complex and antibody reaction compound bound thereon.
Claim 11
Dependent Claim 26 words
Process according to claim 7, wherein the binding of the antibody reaction component to the protein A is by covalent binding via a heterobifunctional photoactivatable compound.
Claim 12
Dependent Claim 15 words
Process according to claim 8, wherein the heterobifunctional photoactivatable compound is N-hydroxysuccinimidyl-4-azidosalicyclic acid or N-succinimidyl-6-(4'-azido-2'-nitrophenylamino)-hexanoate.

References Cited (Backward Citations)

US3995018A Cited
US3995018B1 Cited
US3995018B2 Cited
US3896217A Cited
US4046723A Cited
US4478946A Cited
US4608246A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-12-28 1991-06-29 1991-12-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-12-28 1995-06-29 1995-12-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-12-28 1999-06-29 1999-12-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag